Bio-Techne Corp (TECH) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $57.92
• Market Cap: $9.05B
• P/E Ratio: 109.19
• EPS: $0.53
• 52-Week High: $72.06
• 52-Week Low: $45.74

Market Sentiment

Bio-Techne Corp currently has a Bullish sentiment score of 0.20.

About Bio-Techne Corp

Bio-Techne Corporation (Ticker: TECH) is a premier global provider of high-quality life science reagents, instruments, and services, with a strong focus on clinical diagnostics and research applications. Based in Minneapolis, Minnesota, the company utilizes cutting-edge technologies to drive innovation across key areas such as genomics, proteomics, and cellular analysis. Bio-Techne supports a wide range of clients, including academic institutions, pharmaceutical companies, and clinical labora...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Bio-Techne Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TECH pay dividends?

Bio-Techne Corp (TECH) does not currently pay a regular dividend.

What is TECH's P/E ratio?

Bio-Techne Corp has a price-to-earnings (P/E) ratio of 109.19.

What is TECH's market cap?

Bio-Techne Corp (TECH) has a market capitalization of $9.05B with a current stock price of $57.92.